Capital International Investors Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Capital International Investors

$475 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $23,626 - $24,823	-163 Reduced 0.01%	1,525,202 $231 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $96.2 Million - $169 Million	-1,157,551 Reduced 43.15%	1,525,365 $222 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $256 Million - $332 Million	-2,322,910 Reduced 46.4%	2,682,916 $318 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $35.8 Million - $53.3 Million	-359,239 Reduced 6.7%	5,005,826 $690 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $27.3 Million - $38.3 Million	-275,997 Reduced 4.89%	5,365,065 $745 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $4.13 Million - $6.6 Million	62,830 Added 1.13%	5,641,062 $548 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $15.8 Million - $22.7 Million	247,254 Added 4.64%	5,578,232 $381 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $27.1 Million - $40.9 Million	-416,207 Reduced 7.24%	5,330,978 $457 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $15.5 Million - $20.5 Million	-262,830 Reduced 4.37%	5,747,185 $374 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $182,182 - $466,164	6,280 Added 0.1%	6,010,015 $439 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $84.8 Million - $177 Million	3,082,031 Added 105.49%	6,003,735 $204 Million
Q4 2019 Feb 18, 2020	BUY	$40.86 - $57.65 $61.6 Million - $87 Million	1,508,804 Added 106.79%	2,921,704 $159 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $747,600 - $989,400	20,000 Added 1.44%	1,412,900 $58.9 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $55.4 Million - $93.3 Million	1,392,900 New	1,392,900 $61 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account